EUVIMEDEUVIMED entdecken
Leserbrief

Reconsidering Asparaginase in Leukemia Therapy

Maria Frost, Vivek Subbiah, Branko Cuglievan, Miriam B Garcia

Acta Haematologica · 13.03.2026 · 1-3

DOI: 10.1159/000551486 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Acta Haematologica, online erschienen am 13.03.2026. Verfasst von Maria Frost und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AsparaginaseChemotherapy eliminationImmunotherapyLeukemiaToxicity

Autor:innen und Institutionen

  • Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, mbgarcia@mdanderson.org.

Zitieren

APA

Frost, M., Subbiah, V., Cuglievan, B., & Garcia, M. B. (2026). Reconsidering Asparaginase in Leukemia Therapy. Acta Haematologica, 1-3. https://doi.org/10.1159/000551486

Vancouver

Frost M, Subbiah V, Cuglievan B, Garcia MB. Reconsidering Asparaginase in Leukemia Therapy. Acta Haematologica. 2026:1-3. doi:10.1159/000551486

BibTeX
@article{Frost2026,
  author = {Frost, Maria and Subbiah, Vivek and Cuglievan, Branko and Garcia, Miriam B},
  title = {Reconsidering Asparaginase in Leukemia Therapy},
  journal = {Acta Haematologica},
  year = {2026},
  pages = {1--3},
  doi = {10.1159/000551486}
}
Kostenlos starten →